Mads B. Grønhøj

Medicine & Life Sciences

1. Bacterial Meningitides 87%
2. Biomarkers 19%
3. Biopsy 34%
4. Brain 14%
5. Calcium-Binding Proteins 88%
6. Cerebrospinal Fluid 12%
7. Cohort Studies 48%
8. Coma 10%
9. Deep Brain Stimulation 41%
10. Denmark 10%
11. Drainage 60%
12. Elasticity Imaging Techniques 86%
13. Essential Tremor 95%
14. Fibrosis 10%
15. Hematologic Tests 21%
16. Hematoma, Subdural, Chronic 100%
17. IgA receptor 93%
18. Immobilization 20%
19. Inbred C57BL Mouse 16%
20. Infarction 11%
21. Intensive Care Units 16%
22. Interleukin-6 54%
23. Interleukin-6 Receptors 11%
24. Intermediate Filaments 78%
25. Length of Stay 15%
26. Light 50%
27. Lymphoma 47%
28. Meninges 18%
29. Meningioma 76%
30. Middle Cerebral Artery Infarction 34%
31. Neoplasms 18%
32. Neurosurgery 15%
33. Non-Hodgkin's Lymphoma 26%
34. Observation 14%
35. Palliative Care 27%
36. Phosphopyruvate Hydratase 83%
37. Progression-Free Survival 38%
38. Prospective Studies 45%
39. Randomized Controlled Trials 47%
40. Recurrence 17%
41. Serum 34%
42. Solitary Fibrous Tumors 20%
43. Spinal Cord 11%
44. Spinal Puncture 12%
45. Stroke 48%
46. Surgeons 25%
47. Survival 23%
48. Survivors 12%
49. Thalamus 35%
50. Therapeutics 23%